Ryman Healthcare Limited
RHCGFOTCHealthcare● Active
$1.41
+$0.00(+0.00%)
Market Cap$1.4B
P/E Ratio—
52W High$3.11
52W Low$1.21
Ryman Healthcare Limited（RHCGF）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · RHCGF · 截至 2026-06-10
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2026-03 | 2025-03 | 2024-03 | 2023-03 | 2022-03 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | ($0.17B) | $0.00B | $0.00B | $0.26B | $0.69B |
| Depreciation & Amort. | $0.04B | $0.00B | $0.00B | $0.05B | $0.04B |
| Stock-Based Comp. | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Change in Working Capital | $0.38B | $0.00B | $0.67B | $0.66B | $0.57B |
| Net Cash from Operations | $0.32B | $0.41B | $0.66B | $0.54B | $0.54B |
| Investing Activities | |||||
| Capital Expenditure | ($0.05B) | ($0.11B) | ($0.17B) | ($0.32B) | ($0.30B) |
| Purchases of Investments | ($0.16B) | ($0.38B) | ($0.58B) | ($0.61B) | ($0.43B) |
| Sales of Investments | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Cash from Investing | ($0.13B) | ($0.53B) | ($0.84B) | ($0.93B) | ($0.74B) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00B | $0.00B | ($0.00B) | $0.00B | ($0.00B) |
| Dividends Paid | $0.00B | $0.00B | $0.00B | ($0.07B) | ($0.11B) |
| Debt Issued / Repaid | ($0.19B) | ($0.88B) | $0.20B | $0.44B | $0.33B |
| Net Cash from Financing | ($0.20B) | $0.09B | $0.20B | $0.39B | $0.21B |
| Free Cash Flow | |||||
| Free Cash Flow | $0.28B | $0.30B | $0.49B | $0.22B | $0.24B |
| FCF Margin %(computed) | 34.11% | 42.43% | 74.75% | 39.02% | 47.11% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · NZD · B
深入了解Ryman Healthcare Limited
关于Ryman Healthcare Limited（RHCGF）现金流量表
Ryman Healthcare Limited 2026财年经营活动现金流$0.32B，自由现金流$0.28B（FCF利润率34.11%），资本支出($0.05B)。
常见问题
RHCGF · 4 问Ryman Healthcare Limited 2026财年自由现金流$0.28B，同比down9.2%。
RHCGF free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10